Despite persistent rumors, there really is a monkeypox virus. People even can be vaccinated after exposure to monkeypox virus to help prevent monkeypox disease (i.e., post-exposure prophylaxis).
If your doctor tells you there is no treatment, please download the information on how to access the vaccine and give it to your doctor, or share the link with your doctor.
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the JYNNEOS vaccine to allow healthcare providers to use the vaccine by intradermal injection for individuals 18 years of age and older who are determined to be at high risk for monkeypox infection.
JYNNEOS, the Modified Vaccinia Ankara (MVA) vaccine, was approved in 2019 for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. JYNNEOS is administered beneath the skin (subcutaneously) as two doses, four weeks (28 days) apart.
Two vaccines may be used for the prevention of monkeypox disease:
The JYNNEOS vaccine is approved for the prevention of monkeypox and smallpox disease.
The ACAM2000 vaccine is approved for immunization against smallpox disease and made available for use against monkeypox under an Expanded Access Investigational New Drug (EA-IND) protocol.
For details from the CDC, click here. This is the page you want to give a doctor who does not know about the vaccine.
For details from the FDA, click here.